Background and objectives Thrombotic microangiopathy (TMA) in ANCA-associated vasculitis (AAV) has been mainly reported in isolated case reports. The aim of this study was to analyze clinical and pathologic characteristics and prognosis of patients with renal TMA in ANCA-associated GN in a large cohort of Chinese patients.
Introduction
ANCA-associated vasculitis (AAV) is a group of systemic autoimmune diseases characterized by pauciimmune necrotizing small-vessel vasculitis and circulating autoantibodies against neutrophil cytoplasmic constituents, especially proteinase 3 and myeloperoxidase. AAV comprises granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and renal-limited vasculitis (RLV) (1) . The kidney is one of the most vulnerable organs, often presenting with rapidly progressive GN. The diagnostic and prognostic value of the renal biopsy in ANCA-associated GN is widely recognized. Moreover, the histopathologic classification of ANCA-associated GN proposed by Berden et al. (2) has greatly prioritized the role of renal biopsy findings in the prognostication of patients at the time of diagnosis.
Thrombotic microangiopathy (TMA) comprises a group of clinical and pathologic syndromes that share a similar pathologic process, characterized by endothelial and blood cell damage and thrombotic microvascular occlusions. TMA comprises a spectrum of distinct disorders, including typical and atypical hemolytic uremic syndrome (HUS), congenital and acquired thrombotic thrombocytopenic purpura, malignant hypertension, pregnancy, organ transplantation, drugs, or systemic autoimmune diseases. Renal involvement is common in TMA.
To our knowledge, TMA in ANCA-associated GN has only been reported in isolated case reports (3) (4) (5) (6) (7) (8) (9) , with two patients showing pathologic features of renal TMA. The clinicopathologic characteristics, especially the prognostic value of pathologic findings of renal TMA, in ANCA-associated GN are far from clear. The aim of this study was to analyze clinical and pathologic characteristics and the prognosis of patients with renal TMA in ANCA-associated GN in a large cohort of Chinese patients.
Materials and Methods

Patients
A total of 220 consecutive patients with ANCA-associated GN who received renal biopsy, diagnosed in the Department of Nephrology, Peking University First Hospital from 1996 to 2013, were analyzed retrospectively. Renal biopsy was performed at the time of diagnosis and before the initiation of immunosuppressive therapy. All patients met the criteria of the 2012 Chapel Hill Consensus Conference definition for AAV (1) . Patients with comorbid renal disease or secondary vasculitis, such as membranous glomerulonephropathy, anti-glomerular basement membrane disease, drug-induced vasculitis, or lupus nephritis, were excluded. Patients with EGPA were also excluded because EGPA is increasingly considered a distinct type of AAV with different manifestations and outcomes compared with GPA, MPA, and RLV (10) . The details of the recruitment process are shown in Figure 1 .
Renal TMA was defined as interlobular artery and arteriole and glomerular capillary lesions, including endothelial cell swelling, lumen narrowing, or obliteration and thrombi formation by light microscopy. Swelling of glomerular endothelial cells, detachment from the glomerular basement membrane, and widening of the subendothelial space were identified by electron microscopy (11) . The lesions were further divided into acute and chronic changes. The acute lesion was characterized by swelling of the endothelial cells and subendothelial space; fibrin thrombi may also be seen in the afferent glomeruli, small arterioles, and/or arteries. Chronic changes were mucoid changes and onion skin lesions of arterioles and/or arteries (11) . Known causes of renal TMA, including SLE, anti-phospholipid syndrome, scleroderma, pregnancy-associated TMA, malignant hypertension, transplantation-associated TMA, disseminated intravascular coagulation, drug-mediated TMA, and TMA associated with various infections, including HIV, hepatitis B virus, and hepatitis C virus, were further excluded. Informed consent for renal biopsy was obtained from each patient. The research was in compliance with the Declaration of Helsinki and was approved by the local ethical committees of Peking University First Hospital.
Follow-up was performed in outpatient clinics specific for AAV. The primary end point was defined as death, and the secondary end point was defined as ESRD. The combined end point was defined as a composite outcome of death or ESRD.
Detection of ANCA
ANCA tests were performed by both indirect immunofluorescence assay and antigen-specific ELISA for all patients at the time of presentation and before immunosuppressive treatment was instituted, according to the manufacturer's instruction (Euroimmun, Lübeck, Germany).
Detection of Disintegrin and Metalloproteinase with a Thrombospondin Type 1 Motif, Member 13 Activity
The Disintegrin and Metalloproteinase with a Thrombospondin Type 1 Motif, Member 13 (ADAMTS-13) activity assay was assessed using a residual collagen-binding assay, slightly modified as previously described (12) (Supplemental Material). Data are reported as the percentage of collagenbinding activity remaining after dialysis compared with the collagen binding activity in the individual's baseline sample. One hundred percent minus the residual collagen-binding activity was arbitrarily regarded as the ADAMTS-13 activity.
Renal Histopathology
Biopsies were separately scored by two pathologists blinded to the clinical data, according to the previously standardized protocol for scoring renal biopsies of patients with AAV (13) (14) (15) . In short, each glomerulus was scored separately on the presence of crescents (cellular/fibrous), glomerulosclerosis (local/segmental/global), fibrinoid necrosis, and a number of other lesions. Interstitial and tubular lesions were scored semiquantitatively on the basis of the percentage of the tubulointerstitial compartment that was affected: tubular atrophy(-for 0%, + for 1%-50%, and ++ for.50%), interstitial infiltrates (-for 0%, + for 1%-20%, ++ for 21%-50%, and +++ for .50%), and interstitial fibrosis (-for 0%, + for 1%-50%, and ++ for .50%). Each biopsy was further classified as sclerotic, focal, crescentic, or mixed category, according to the histopathologic classification system of ANCA-associated GN proposed by Berden et al. (2) .
Treatment and Response
The treatment protocols have been described previously (16, 17) . For a detailed description, see the Supplemental Material. Briefly, the induction therapy included corticosteroids in combination with cyclophosphamide. Patients with ARF or pulmonary hemorrhage received three pulses of intravenous methylprednisolone before the standard induction therapy. Patients with severe pulmonary hemorrhage additionally received plasma exchanges. For maintenance therapy, intravenous cyclophosphamide every 3 months or daily oral azathioprine was given, with a duration of at least 2 years. The response to the immunosuppressive treatment was defined as previously described (18) (detailed in the Supplemental Material). The renal response to treatment, evaluated at 6 months after initiation of immunosuppressive therapy, was judged according to the following criteria: (1) complete recovery of renal function was indicated by normalization of renal function and resolution of hematuria; (2) partial recovery of renal function was indicated by stabilization or improvement of renal function, with serum creatinine $1.5 mg/dl but dialysis independent; and (3) treatment failure was indicated by progressive decline in kidney function with persistence of active urinary sediment despite immunosuppressive therapy (19) (20) (21) .
Statistical Analyses
The t test, nonparametric test, and chi-squared test were performed as appropriate. Kaplan-Meier curves were used to analyze the outcomes of patients. All of the clinicopathologic parameters and treatment regimens listed in Tables 1-3 were assessed as candidate predictors in the univariate survival analysis. If the P value was ,0.05, this predictor was allowed to be included in multivariable Cox regression models. Tubular atrophy and interstitial fibrosis were also included in the multivariable models because they were potential histopathologic predictors according to previous study (22) . Because of the close correlation between initial serum creatinine and the sequence of histopathologic categories proposed by Berden et al.
(r=0.53, P,0.001), the two parameters were separately included in the multivariate analysis using models A and B, respectively. Interaction effect of age and renal TMA on all-cause mortality was also investigated. Differences were considered significant if the P value was ,0.05. Analysis was performed with SPSS version 11.0 statistical software package (SPSS, Chicago, IL). 
Results
General Data of Patients
Among the 220 patients with ANCA-associated GN enrolled in this study, 30 (13.6%) were identified having concomitant renal TMA by pathologic evaluation ( Figure  2 ). Renal TMA in ANCA-associated GN was equally distributed in time in our cohort during the study period, with a prevalence of five of 43 (11.6%), 13 Among the 30 AAV patients with renal TMA, 15 (50.0%) were men and 15 (50.0%) were women, with an average age of 63.9611.3 (range, 20-81) years at diagnosis. According to the 2012 Chapel Hill Consensus Conference definitions (1), 24 of 30 (80.0%), four of 30 (13.3%), and two of 30 (6.7%) were classified as MPA, GPA, and RLV, respectively. None of the 30 patients with TMA had concomitant infections with HIV, hepatitis B virus, or hepatitis C virus. According to the pathologic features previously described, seven patients presented with solely acute lesions, seven patients presented with solely chronic lesions, and 16 patients presented with both acute and chronic lesions.
Serum ADAMTS-13 Activity
None of the patients with renal TMA in our study presented with a deficiency of serum ADAMTS-13 activity, with a median activity of 98.6% (range, 97.1%-99.6%).
Clinical and Laboratory Parameters
The clinical and laboratory features of patients in the two groups are listed in 
Renal Histopathology
An average of 24.7611.7 glomeruli were available for evaluation in the 220 renal biopsies. Parameters of renal histopathology of patients with and without renal TMA are listed in Figure 3 and (Figure 3) , with the proportion of focal category being much lower in the TMA group. Interstitial infiltrates were significantly more severe in patients with renal TMA than in those without 
Treatment and Outcome
Therapy of patients with renal TMA and nonrenal TMA was comparable, with the exception of patients receiving methylprednisolone pulse therapy, the proportion of which was marginally higher in the renal TMA group (P=0.07) ( Table 2 ). After the aforementioned induction (Figure 4A ), whereas there was no significant difference in renal outcome between the two groups (P=0.29) (Figure 4B ). Additionally, when comparing the combined end points (i.e., death, ESRD), patients with renal TMA also had significantly poorer outcomes (P=0.03) ( Figure 4C ). We further compared the prognosis of patients with renal TMA among different categories (solely acute versus acute and chronic versus solely chronic). The Kaplan-Meier survival analysis revealed that patients with acute TMA lesions only had a relatively favorable renal outcome, whereas patients with solely chronic TMA lesions had the highest risk for developing ESRD (P=0.01) (Supplemental Figure 1) .
Univariate survival analysis of long-term prognosis in all patients with ANCA-associated GN showed that renal TMA was associated with all-cause mortality (P=0.004). Besides TMA, variables including age, sex, initial serum creatinine, and the classification scheme proposed by Berden et al. were predictors of death in univariate analysis (Table 3 ). Multivariate analysis revealed that renal TMA was still an independent risk factor for patients' survival after adjusting for age, sex, initial serum creatinine, interstitial fibrosis, and tubular atrophy (hazard ratio, 1.92; 95% confidence interval, 1.08 to 3.41; P=0.03) or for age, sex, the histopathologic classification scheme proposed by Berden et al., tubular atrophy, and interstitial fibrosis (hazard ratio, 1.95; 95% confidence interval, 1.07 to 3.55; P=0.03) ( Table 4 ). Beceause patients with renal TMA were significantly older than those without renal TMA, we also investigated the effect of age and renal TMA on all-cause mortality in the multivariate regression analysis, but no significant interaction was observed (P=0.64).
Discussion
TMA comprises a group of disorders, including HUS, thrombocytopenic purpura, and disease-associated TMA. Renal TMA in AAV has mainly been reported in isolated case reports (3-9). Our study is, to our knowledge, the first to assess clinical and pathologic features and the prognosis of patients with renal biopsy-proven TMA in ANCAassociated GN in a large cohort.
Our study found that renal TMA in ANCA-associated GN is not rare, with a prevalence of 13.6% (30 of 220 patients). In the literature, epidemiologic series reporting the prevalence of renal TMA in total renal biopsies were insufficient. Recently, a large cohort study in our center reported that adult renal TMA accounted for 1.4% (109 of 7589 patients) of the total biopsied patients in the same period (23) . However, the prevalence in other countries is unclear, especially for renal TMA in ANCA-associated GN. As reported in previous case reports, patients with concomitant renal TMA in ANCA-associated GN presented with more severe renal injury (3) (4) (5) (6) (7) (8) (9) . Patients with renal TMA in our cohort also had a higher level of initial serum creatinine, higher percentage of cellular crescents and fibrinoid necrosis, and more severe interstitial infiltration compared with patients without TMA, which, by a large cohort study, further extends previous findings. Meanwhile, no significant differences were observed in chronic lesions, including fibrous crescents, glomerular sclerosis, interstitial fibrosis, and tubular atrophy between patients with and without renal TMA. Therefore, patients with renal TMA had more acute renal diseases. Furthermore, renal TMA was found to be independently associated with all-cause mortality of patients with AAV. It might suggest that patients with TMA in AAV should receive more Tubulointerstitial lesions were scored semiquantitatively on the basis of the percentage of the affected compartment: interstitial infiltrates (2 for 0%, + for 1%-20%, ++ for 21%-50%, and +++ for .50%), interstitial fibrosis (2 for 0%, + for 1%-50%, and ++ for .50%), and tubular atrophy (2 for 0%, + for 1%-50%, and ++ for .50%). TMA, thrombotic microangiopathy.
intensive immunosuppressive therapy, such as plasma exchange, as described in previous case reports (3) (4) (5) (6) (7) (8) .
In this study, TMA was associated with mortality, rather than ESRD. Considering that TMA is a pathologic process with multiple organs involved, we speculate that the extrarenal disorder of TMA is a possible explanation for patients' poor long-term survival. In our cohort, the higher proportion of crescents and the more severe interstitial inflammation observed in patients with renal TMA, compared with those without TMA, might be indicative of overall cellular activation. However, because this study is a retrospective one, direct evidence of extrarenal microvascular lesions was not available in some patients, especially during follow-up; the contribution of extrarenal TMA to the mortality in patients with AAV needs to be confirmed by prospective studies.
The pathogenesis of renal TMA in ANCA-associated GN and why only a small subset of patients with ANCA GN developed TMA is far from clear. However, we observed that greater than one in eight patients with AAV combined with TMA, which suggests that, rather than a casual phenomenon, these two entities may share a common pathophysiologic process. Theoretically, there are several potential explanations. First, considering the pathologic features of TMA, endothelial damage has long been regarded as an important disease mechanism in TMAs (24) . On the other hand, ANCA-mediated activation of neutrophils that results in endothelial injury is the basic pathophysiologic mechanism involved in AAV (25) . It seems that TMA and AAV share the same target cells, namely, endothelial cells, which may contribute to the development of renal TMA in ANCA-associated GN. Second, the complement system might be another potential contributor. Although AAV has traditionally been characterized as pauci-immune, and decreased levels of circulating C3 are uncommon in AAV, recent studies have demonstrated that activation of the alternative complement pathway plays a critical role in the pathogenesis of AAV (26) (27) (28) (29) (30) . Patients with active AAV have elevated levels of circulating C3a, C5a, soluble C5b-9, and Bb, which suggests activation of the complement system via the alternative pathway (30) . As for TMA, a variety of hereditary and acquired disorders, which contribute to the loss of alternative pathway regulation on endothelial cells and on the surface of platelets, have been documented and predispose patients to TMA susceptibility (31) (32) (33) (34) . Indeed, it has been suggested that most TMAs are characterized by misdirected complement activation affecting endothelial cell and platelet integrity (34) . Therefore, we speculate that systemic activation of complement, especially the alternative complement pathway, might play an important role in the development of renal TMA in AAV. Animal studies in AAV have suggested a potential therapeutic role of anti-C5 intervention (27, 28, 35) , and clinical trials with CCX168, a small molecule antagonist of the human C5aR, are ongoing (36) . Moreover, eculizumab, a human C5 inhibitor, has been found to be remarkably efficient for the treatment of atypical haemolytic uraemic syndrome (37) . Whether anti-C5 therapy is beneficial in the treatment of patients with TMA in AAV could be of interest to study in the future. Third, neutrophil extracellular traps (NETs) have been shown to participate in the pathogenesis of AAV (38, 39) . Interestingly, a recent study suggested the formation of NETs as a second hit that precipitates acute disease in patients at risk for TMA (40) . Therefore, NETs might be relevant to the occurrence of TMA in AAV. Finally, severe lesion of AAV might act as another potential trigger for mediating a secondary TMA reaction. Collectively, we speculate that the occurrence of TMA in AAV is a multifactorial process. The exact mechanism is of great interest for further investigation.
Our study has several limitations. Because it is a retrospective and observational study, it is difficult to sort out whether the TMA is secondary to more severe disease or whether the TMA is a causal factor of the more severe disease caused by a separate primary TMA process. In previous case reports (4-8), it was suggested that TMA in AAV is more likely to be a disorder secondary to ANCAassociated GN. However, this contention needs to be confirmed in future studies. Furthermore, limited by the relatively small sample size in each subgroup of TMA (i.e., solely acute lesions, acute and chronic lesions, solely chronic lesions), the results of renal outcomes of patients with renal TMA among different categories needs to be validated in larger cohorts.
In conclusion, renal TMA in ANCA-associated GN is not rare, and it presents with more severe renal injury. Renal TMA is independently associated with all-cause mortality of patients with AAV. 
